InvestorsHub Logo
Followers 507
Posts 10138
Boards Moderated 0
Alias Born 04/28/2014

Re: None

Thursday, 07/23/2015 3:29:23 PM

Thursday, July 23, 2015 3:29:23 PM

Post# of 2
$PXSLY recent news/filings

bullish
bull flag

## source: finance.yahoo.com

Mon, 18 May 2015 02:03:00 GMT ~ Boehringer Ingelheim Acquires Pharmaxis' Phase 1 Anti-inflammatory Drug Candidate

[PR Newswire] - Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis' investigational anti-inflammatory drug candidate PXS4728A, including associated intellectual property rights. PXS4728A is a highly selective oral small molecule inhibitor of vascular adhesion protein-1 that has shown activity in pre-clinical investigation in non-alcoholic steatohepatitis (NASH). The acquisition of this investigational anti-inflammatory drug-candidate adds a highly innovative approach to Boehringer Ingelheim's clinical development portfolio. Pharmaxis is transformed by significant deal size and recognition of its drug discovery expertise.

read full: http://finance.yahoo.com/news/boehringer-ingelheim-acquires-pharmaxis-phase-020300438.html
*********************************************************

Mon, 12 Jan 2015 15:38:04 GMT ~ 12.01.2015 - Appendix 3B - Exercise of Employee Options

[at noodls] - 12.01.2015 - Appendix 3B - Exercise of Employee Options

read full: http://www.noodls.com/view/D900CA09BF19F0CB34F9D01D85072BEA603F2422
*********************************************************

Tue, 23 Dec 2014 22:08:49 GMT ~ 23.12.2014 - PHARMAXIS ANNOUNCES SIGNIFICANT BUSINESS MILESTONES

[at noodls] - Under the terms of the commercialisation agreement Chiesi is responsible for funding up to US$22 million of the cost of the phase 3 clinical trial of Bronchitol which recently enrolled its first patient. ...

read full: http://www.noodls.com/view/05E7F9D455EEC8EAB703F6499009148D5AE10AD6
*********************************************************

Thu, 30 Oct 2014 03:42:41 GMT ~ 30.10.2014 - ASx Quarterly Cash Flow - September 2014

[at noodls] - 30.10.2014 - ASx Quarterly Cash Flow - September 2014

read full: http://www.noodls.com/view/7674754E74DF9794F15B1D03BD418CBAEF39179C
*********************************************************

Thu, 30 Oct 2014 02:43:27 GMT ~ 30.10.2014 - Quarterly Shareholder Update - September 2014

[at noodls] - 30.10.2014 - Quarterly Shareholder Update - September 2014

read full: http://www.noodls.com/view/9392EF0E9C436D01DD612035FBC9AA4AD8D0E504
*********************************************************

$PXSLY charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$PXSLY company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PXSLY/company-info
Ticker: $PXSLY
OTC Market Place: OTC Pink Current
CIK code: 0001301357
Company name: Pharmaxis Ltd.
Company website: http://www.pharmaxis.com.au
Incorporated In: Australia
$PXSLY share structure

## source: otcmarkets.com

Market Value: $35,613,287 a/o Jul 22, 2015
Shares Outstanding: 228,290,300 a/o Jul 21, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

$PXSLY extra dd links

Company name: Pharmaxis Ltd.
Company website: http://www.pharmaxis.com.au

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PXSLY+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PXSLY+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PXSLY+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/news - http://finance.yahoo.com/q/h?s=PXSLY+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PXSLY/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PXSLY+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PXSLY
DTCC (dtcc.com): http://search2.dtcc.com/?q=Pharmaxis+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Pharmaxis+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Pharmaxis+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.pharmaxis.com.au
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.pharmaxis.com.au#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.pharmaxis.com.au

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PXSLY
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001301357&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PXSLY&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PXSLY
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PXSLY+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PXSLY+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PXSLY
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PXSLY
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PXSLY+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PXSLY/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PXSLY+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PXSLY.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PXSLY
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PXSLY
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PXSLY
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PXSLY:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PXSLY
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PXSLY



$PXSLY DD Notes ~ http://www.ddnotesmaker.com/PXSLY

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.